Amgen 20140444: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
|Effective start/end date||8/1/18 → 7/31/22|
- Amgen Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.